Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.22 -0.58 (-3.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Shares Outstanding (Entity) (2015 - 2026)

Updated

Syndax Pharmaceuticals' Shares Outstanding (Entity) was 89.15 million in Q2 2026, up 3.6% from 86.06 million a year earlier and up 0.7% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at Syndax Pharmaceuticals came in at 87.41 million, up 2.0% from FY2024.

  • Shares Outstanding (Entity) has now increased for nine consecutive years, with a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 85.69 million in FY2024 (+21.8%), 70.37 million in FY2023 (+3.3%), 68.11 million in FY2022 (+23.9%) and 54.98 million in FY2021 (+14.8%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2015.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 38 straight quarters, with growth averaging 7.1% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 1.2% (Q2 2025) to 25.8% (Q3 2021).
  • Per Business Quant data, SNDX's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 88.54 million (Q1 2026), 87.41 million (Q4 2025) and 86.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn 89.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89.15 Mn
Mar 31, 2026 88.54 Mn
Dec 31, 2025 87.41 Mn
Sep 30, 2025 86.91 Mn
Jun 30, 2025 86.06 Mn
Mar 31, 2025 86.05 Mn
Dec 31, 2024 85.69 Mn
Sep 30, 2024 85.57 Mn
Jun 30, 2024 85.03 Mn
Mar 31, 2024 84.98 Mn
Dec 31, 2023 70.37 Mn
Sep 30, 2023 69.64 Mn
Jun 30, 2023 69.43 Mn
Mar 31, 2023 68.50 Mn
Dec 31, 2022 68.11 Mn
Sep 30, 2022 60.12 Mn
Jun 30, 2022 56.40 Mn
Mar 31, 2022 55.03 Mn
Dec 31, 2021 54.98 Mn
Sep 30, 2021 48.85 Mn
API Access

Syndax Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SNDX&period=max&api_key=YOUR_API_KEY